Telix Pharmaceuticals | TLX - Ordinary Share Capital


Telix Pharmaceuticals reported AUD339.78M in Ordinary Share Capital for its fiscal semester ending in June of 2026.





Ordinary Share Capital Change Date
Cochlear AUD 65.4M 1.12B Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Integral Diagnostics AUD 335.09M 1.07M Jun/2024
Mayne Pharma AUD 81.25M 0 Jun/2025
Medical Developments International AUD 112.66M 2.35M Dec/2025
Mesoblast USD 1.3B 8.15M Jun/2026
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Pacific Edge NZD 1.02B 497K Jun/2026
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
Polynovo AUD 690.84M 991 Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Ramsay Health Care AUD 229.93M 29.81K Dec/2025
ResMed USD 145.04M 621.52K Mar/2026
Sonic Healthcare AUD 4.15B 467K Dec/2024